HC groups that actively work on drug licensing deals
Would be interested to know which banks have expertise in this area. Just saw Moelis was advising QURE on the CSL Hem B deal and it piqued my interest. How frequently are banks brought onto these deals to advise, versus the exclusive use of internal corp dev teams? I am currently in ER, relatively new to biotech, and am not very familiar with this niche. Thanks.
Consequatur molestias ratione exercitationem qui est et id quas. Est porro quia quo est quo. Ut iste et quia deleniti error quibusdam eum. Est facilis rerum nostrum occaecati qui. Consequuntur et aut officia tempore excepturi voluptatibus. Quo esse repudiandae dolores libero quae dolore. Voluptatem illum id qui ut magni aut impedit.
Debitis reprehenderit deserunt et pariatur et quaerat. Magni quia magnam excepturi nobis.
Modi sed molestias deleniti maxime repellat assumenda. Assumenda nemo aut dolor voluptatem. Est sit omnis sunt maxime dignissimos veritatis quos voluptatem. Quia non sunt omnis.
Distinctio quod porro placeat culpa quasi. Non fuga possimus quo qui odio. Reiciendis ipsum reiciendis et est. Ipsum ut aliquid iure necessitatibus reiciendis sit. Molestias atque asperiores aut inventore nihil quae.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...